Company Overview - Zhongshan Bailing Biotechnology Co., Ltd. was established on April 6, 2004, with a registered capital of 7.065 million yuan [1] - The company is located in Zhongshan Torch Development Zone, Guangdong Province, and specializes in the production of bile acid raw materials [1] - Main products include Ursodeoxycholic Acid (UDCA) and Chenodeoxycholic Acid (CDCA) [1] Shareholding Structure - The controlling shareholder is Zhongshan Langchen Biotechnology Co., Ltd., holding a direct stake of 67.49% [2] - Zhang Heping serves as the legal representative and chairman of Bailing Biotechnology, holding approximately 44% of Langchen Biotechnology [2] Key Personnel - Zhang Wei, another shareholder, is the chairman of Shenzhen Jicheng Venture Capital Management Co., Ltd. [5] - Zhang Wei is recognized as a prominent investor, having received multiple awards including "Top 10 Chinese Venture Capitalists" and "Top 100 in Chinese Venture Capital 2024" [7]